Aposense receives recognition for molecular imaging platform

11/6/2008 | Genetic Engineering & Biotechnology News

Aposense has received the 2008 European Technology Innovation of the Year Award in molecular/cellular imaging for its Aposense technology platform used in targeting and imaging of apoptosis, also known as programmed cell death, in medical imaging, personalized medicine and drug-development applications. The award is given to a company that has undertaken innovative research and whose work is expected to impact future adoption, change and competitive trends in the industry.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC